Menu Search
Equities

Paragon Care Ltd

  • Add to watchlist
  • Add to portfolio
  • Add an alert
PXS:STU

Paragon Care Ltd

Actions
  • Price (EUR)0.112
  • Today's Change0.00 / 0.00%
  • Shares traded0.00
  • 1 Year change-64.78%
  • Beta1.7938
Data delayed at least 15 minutes, as of Feb 13 2026.
More ▼
Notice
Important Notice
Please note that effective 5th February, 2026 the Financial Times will no longer publish or present securities from the Nairobi Stock Exchange.

Profile data is unavailable for this security.

About the company

Paragon Care Limited is an Australia-based company, which is engaged in the healthcare sector. The Company is a provider of medical equipment, devices, consumables, pharmaceuticals, complementary medicines, nutritional supplies, and manufacturer of Blood Bank diagnostic reagents to the healthcare markets in Australia, New Zealand and Asia. The Company’s geographical segments comprise Australia & New Zealand and Asia. It also offers equipment repair, maintenance and total equipment management through ParagonCare Service & Technology. Its CH2 brand distributes pharmaceutical, medical consumables, nutritional and over the counter products medical equipment and medical supplies. Its product portfolio includes critical care, dental, diagnostic & scientific, medical products & consumables, neonatal, orthopedics, service, surgical, technology & connectivity, urology, veterinary and aesthetics. Its brands include ParagonCare Immulab, ParagonCare Veterinary, Medtek, and Western Biomedical.

  • Revenue in AUD (TTM)3.62bn
  • Net income in AUD20.57m
  • Incorporated1994
  • Employees0.00
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.